Compare Mutual Funds
Risk
Very High
-
Rating
1.0
-
Min SIP Amount
₹200
-
Expense Ratio
2.36
-
NAV
₹28.51
-
Fund Started
08 Feb 2019
-
Fund Size
₹78.65 Cr
-
Exit Load
Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.
-
1 Year
5.45%
-
3 Year
21.88%
-
5 Year
12.00%
-
Equity
95.49%
-
Cash
4.51%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 10.64% |
Torrent Pharmaceuticals Ltd. | 6.61% |
Apollo Hospitals Enterprise Ltd. | 5.95% |
Aurobindo Pharma Ltd. | 4.81% |
Divi's Laboratories Ltd. | 4.74% |
Fortis Healthcare Ltd. | 4.66% |
Neuland Laboratories Ltd. | 4.36% |
Piramal Pharma Ltd. | 4.29% |
Alkem Laboratories Ltd. | 3.62% |
Abbott India Ltd. | 3.39% |
-
Name
-
-
Start Date
-
-
Description
The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
-
Launch Date
08 Feb 2019
-
